[Federal Register Volume 82, Number 93 (Tuesday, May 16, 2017)]
[Notices]
[Pages 22550-22551]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-09778]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Solicitation of Nominations for Appointment to the Presidential 
Advisory Council on Combating Antibiotic-Resistant Bacteria

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The U.S. Department of Health and Human Services (HHS) is 
soliciting nominations of individuals who are interested in being 
considered for appointment to the Presidential Advisory Council on 
Combating Antibiotic-Resistant Bacteria (Advisory Council) as a non-
voting liaison representative member from an organization and/or 
interest group. Nominations from qualified individuals who wish to be 
considered for appointment to this member category of the Advisory 
Council are currently being accepted.

DATES: Nominations must be received no later than 5:00 p.m. ET on June 
30, 2017.

ADDRESSES: Information on how to submit a nomination is on the Advisory 
Council Web site, http://www.hhs.gov/ash/carb/.

FOR FURTHER INFORMATION CONTACT: MacKenzie Robertson, Committee 
Management Officer, Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for 
Health, U.S. Department of Health and Human Services, Room 715H, Hubert 
H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 
20201. Phone: (202) 690-5566; email: [email protected]. The Advisory Council 
charter may be accessed online at http://www.hhs.gov/ash/carb/. The 
charter includes detailed information about the Advisory Council's 
purpose, function, and structure.

SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September 
18, 2014, authority was given to the Secretary of HHS to establish the 
Advisory Council, in consultation with the Secretaries of Defense and 
Agriculture. Activities of the Advisory Council are governed by the 
provisions of Public Law 92-463, as amended (5 U.S.C. App.), which sets 
forth standards for the formation and use of federal advisory 
committees. The Advisory Council will provide advice, information, and 
recommendations to the Secretary of HHS regarding programs and policies 
intended to preserve the effectiveness of antibiotics by optimizing 
their use; advance research to develop improved methods for combating 
antibiotic resistance and conducting antibiotic stewardship; strengthen 
surveillance of antibiotic-resistant bacterial infections; prevent the 
transmission of antibiotic-resistant bacterial infections; advance the 
development of rapid point-of-care and agricultural diagnostics; 
further research on new treatments for bacterial infections; develop 
alternatives to antibiotics for agricultural purposes; maximize the 
dissemination of up-to-date information on the appropriate and proper 
use of antibiotics to the general public and human and animal 
healthcare providers; and improve international coordination of efforts 
to combat antibiotic resistance.
    The Advisory Council is authorized to consist of not more than 30 
members, including the voting and non-voting members and the Chair and 
Vice Chair. The current composition of the Advisory Council consists of 
15 voting members, including the Chair and Vice Chair, five non-voting 
liaison representative members, and 10 non-voting ex-officio members. 
The non-voting liaison representatives are selected from organizations 
and/or interest groups that have involvement in the development, 
testing, licensing, production, procurement, distribution, and/or use 
of antibiotics and/or antibiotic research. Organizations are invited to 
participate as non-voting liaison representatives as it is deemed 
necessary by the Secretary or designee to accomplish the established 
mission of the Advisory Council.
    This announcement is to solicit nominations to fill positions that 
are scheduled to be vacated during the 2017 calendar year in the non-
voting liaison representative member category. Non-voting liaison 
representative members are appointed to serve two-year terms. 
Individuals from the following sectors are being sought to serve a non-
voting liaison representatives: (1) Professional organizations 
representing infectious disease, epidemiology, infection control, 
physicians, nurses, pharmacists, microbiologists, and veterinarians; 
(2) public health organizations representing laboratories, health 
officials, epidemiologists (state/territorial, county, or local); (3) 
organizations advocating for patients and consumers; (4) organizations 
representing state departments of agriculture; (5) hospitals; (6) 
foundations with an interest in antibiotic resistance and promoting 
antibiotic stewardship; (7) pharmaceutical industry--animal and

[[Page 22551]]

human health; (8) food producers--livestock, poultry, and seafood; (9) 
in vitro diagnostics; (10) food retailers; (11) food processors; (12) 
animal feed producers; and (13) farm bio-security.
    Individuals who are appointed to serve as non-voting liaison 
representative members may be allowed to receive per diem and 
reimbursement for any applicable expenses for travel that is performed 
to attend meetings of the Advisory Council in accordance with federal 
travel regulations. The Advisory Council meets, at a minimum, two times 
per fiscal year depending on the availability of funds. Meetings are 
open to the public, except as determined otherwise by the Secretary or 
other official to whom the authority has been delegated in accordance 
with guidelines under the Government in the Sunshine Act, 5 U.S.C. 
552b(c).
    Nominations, including self-nominations, of individuals who 
represent organizations that have the specified expertise and knowledge 
sought will be considered for appointment as non-voting liaison 
representative members of the Advisory Council. Every effort will be 
made to ensure that the Advisory Council is a diverse group of 
individuals with representation from various geographic locations, 
racial and ethnic minorities, all genders, and persons living with 
disabilities. Detailed information on what is required in a nomination 
package and how to submit one is on the Advisory Council Web site, 
http://www.hhs.gov/ash/carb/.

    Dated: April 25, 2017.
Jewel Mullen,
Acting Director, National Vaccine Program Office.
[FR Doc. 2017-09778 Filed 5-15-17; 8:45 am]
 BILLING CODE 4150-28-P